Dr. Thorgeirsson joined the NCI in 1976, and has been the Chief of the Laboratory of Experimental Carcinogenesis since 1981. He obtained his M.D. degree from the University of Iceland; he studied biochemistry and pharmacology with Sir Colin Dollery and Dr. Donald S. Davies at the Royal Postgraduate Medical School in London, England and obtained his Ph.D. from the University of London.
Irwin Arias, M.D.: Training in medicine and liver disease (Harvard). biochemistry (Stanford) and cell biology (UCSD). Professor, Associate Chairman, Department of Medicine; Director, Liver Research Center, Albert Einstein College of Medicine (1957-83). Professor and Chairman, Department of Molecular and Cellular Physiology and Professor of Medicine, Tufts Medical School (1983- ). Adjunct Scientist, NICHD, Head, Unit on Cellular Polarity and Asst. to Director, Intramural Program, NIH (2000-present)
Ph.D. Cornell in Microbiology; USAMRIID immunologist, 1972. Jahrling is the Institute's principal scientific advisor on issues related to medical defense against infectious disease threats. He has authored or co-authored more than 160 scientific publications, chiefly in the areas of filovirus and poxvirus research.
Robbins is a leading contributor to knowledge of the epidemiology, immunology, and prevention of infections caused by encapsulated bacteria. His basic and developmental studies of vaccines of bacterial capsular polysaccharides conjugated to proteins represent a major advance in prevention of the bacterial infections prevalent world wide in infancy and childhood. He was elected to NAS in 1996.